Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 11, 2015 - Issue 6
Submit an article Journal homepage
2,131
Views
18
CrossRef citations to date
0
Altmetric
Editorial

Treating to target in axial spondyloarthritis: defining the target and the arrow

Daniel WendlingDepartment of Rheumatology, CHRU de Besançon, University Teaching Hospital, and Université de Franche-Comté, Boulevard Fleming, F-25030, Besançon, FranceCorrespondence[email protected]
Pages 691-693 | Published online: 23 Apr 2015

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Juan Carlos Torre-Alonso, Rubén Queiro, Marta Comellas, Luís Lizán & Carles Blanch. (2018) Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature. Patient Preference and Adherence 12, pages 733-747.
Read now
Daniel Wendling. (2016) An overview of investigational new drugs for treating ankylosing spondylitis. Expert Opinion on Investigational Drugs 25:1, pages 95-104.
Read now

Articles from other publishers (16)

Diego Benavent, Dafne Capelusnik, Sofia Ramiro & Victoria Navarro-Compán. (2023) Looking through the window of opportunity in axial spondyloarthritis?. Joint Bone Spine 90:6, pages 105603.
Crossref
Ana Sofia Pinto, Bayram Farisogullari & Pedro M Machado. (2022) Predictors of remission in people with axial spondyloarthritis: A systematic literature review. Seminars in Arthritis and Rheumatism 56, pages 152078.
Crossref
Laura Pina Vegas, Emilie Sbidian, Daniel Wendling, Philippe Goupille, Salah Ferkal, Philippe Le Corvoisier, Bijan Ghaleh, Alain Luciani & Pascal Claudepierre. (2022) Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort. Rheumatology 61:4, pages 1487-1495.
Crossref
I. Z. Gaydukova & V. I. Mazurov. (2019) The efficacy of non-sreroidal anti-inflammatory drugs. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:5, pages 134.
Crossref
I Z Gaydukova, A I Akulova & A P Rebrov. (2018) Comorbidities in inflammatory joint and spine diseases in XXI century. Terapevticheskii arkhiv 90:12, pages 90-95.
Crossref
Martin Bergman & Amy Lundholm. (2018) Managing morbidity and treatment-related toxicity in patients with ankylosing spondylitis. Rheumatology 57:3, pages 419-428.
Crossref
XENOFON BARALIAKOS, FRANCIS BERENBAUM, ENNIO GIULIO FAVALLI, IGNAZIO OLIVIERI, BENEDIKT OSTENDORF, DENIS PODDUBNYY & KURT DE VLAM. (2018) Challenges and Advances in Targeting Remission in Axial Spondyloarthritis. The Journal of Rheumatology 45:2, pages 153-157.
Crossref
I. Z. Gaydukova, A. V. Aparkina, E. V. Khondkaryan & A. P. Rebrov. (2018) Effectiveness of the tenoxicam in patients with ankylosing spondylitis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:2, pages 35.
Crossref
I Z Gaydukova, A V Aparkina, E V Khondkaryan & A P Rebrov. (2017) Biomarkers of bone remodeling in ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs: results of an ETHICS research program. Terapevticheskii arkhiv 89:12-2, pages 185-189.
Crossref
Martin Bergman & Amy Lundholm. (2017) Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis. Arthritis Research & Therapy 19:1.
Crossref
Siba P. Raychaudhuri & Smriti K. Raychaudhuri. (2017) Mechanistic rationales for targeting interleukin-17A in spondyloarthritis. Arthritis Research & Therapy 19:1.
Crossref
I Z Gaydukova, E V Khondkaryan, A V Aparkina & A P Rebrov. (2017) Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study. Terapevticheskii arkhiv 89:5, pages 38-45.
Crossref
I Z Gaydukova, A P Rebrov, A V Aparkina & E V Khondkaryan. (2017) Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year. Terapevticheskii arkhiv 89:4, pages 80-85.
Crossref
I. Z. Gaydukova, К. A. Gamayunova, K. D. Dorogoykina & A. P. Rebrov. (2017) Efficiency of different celecoxib regimens in patients with active axial spondyloarthritis: Results of the 4-week pilot open-label comparative single-center study «AIM». Terapevticheskii arkhiv 89:6, pages 78.
Crossref
Chao Chen, XiaoLin Zhang, Lu Xiao, XueSong Zhang & XinLong Ma. (2016) Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis. Medicine 95:11, pages e3060.
Crossref
Peter Bossuyt & Séverine Vermeire. (2016) Treat to Target in Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 14:1, pages 61-72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.